Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. [electronic resource]
Producer: 20071127Description: 1393-402 p. digitalISSN:- 0145-2126
- Acute Disease
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Azacitidine -- administration & dosage
- Bryostatins -- administration & dosage
- Cell Differentiation
- Cell Line, Tumor
- Cholecalciferol -- administration & dosage
- Cytotoxicity, Immunologic
- Decitabine
- Flow Cytometry
- GPI-Linked Proteins
- Humans
- Hydroxamic Acids -- administration & dosage
- Intercellular Signaling Peptides and Proteins -- metabolism
- Killer Cells, Natural -- immunology
- Leukemia, Myeloid -- immunology
- Reverse Transcriptase Polymerase Chain Reaction
- Tretinoin -- administration & dosage
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.